Magnitude of Therapeutic Effects Crucial in FDA Approval of Non-RCT Treatments
The magnitude of therapeutic effects plays an important role in US Food and Drug Administration (FDA) approval of treatments based on nonrandomized clinical trials (RCTs), according to a study published in JAMA Network Open. RCTs are widely used to evaluate the safety and efficacy of new clinical interventions and medical devices. However, RCTs are often…
